Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 08 2020
Historique:
entrez: 12 8 2020
pubmed: 12 8 2020
medline: 2 1 2021
Statut: ppublish

Résumé

To examine longitudinal changes of retinal thickness and retinal sensitivity in patients with intermediate age-related macular degeneration (iAMD) and predominantly reticular pseudodrusen (RPD). At baseline 30 eyes of 25 iAMD patients underwent optical coherence tomography imaging, mesopic and scotopic fundus-controlled perimetry (FCP) with follow-up examinations at month 12 (20 eyes), 24 (12 eyes), and 36 (11 eyes). Thicknesses of different retinal layers and results of FCP testing (n = 56 stimuli) were spatially and longitudinally analyzed using linear mixed-effects models. At baseline, the thickness of the partial outer retinal layer (pORL, 70.21 vs. 77.47 µm) and both mesopic (16.60 vs. 18.72 dB) and scotopic (12.14 vs. 18.67 dB) retinal sensitivity were decreased in areas with RPD compared with unremarkable areas (P < 0.001). Over three years, mean change of pORL was -0.66 normative standard deviation (SD; i.e., z-score, P < 0.001) for regions with existing RPD, -0.40 SD (P < 0.001) for regions with new occurring RPD, and -0.17 SD (P = 0.041) in unremarkable regions. Decrease of scotopic and mesopic sensitivity over three years was more pronounced in areas with existing (-3.51 and -7.76 dB) and new occurring RPD (-2.06 and -5.97 dB). Structure-function analysis revealed that 1 SD decrease of pORL thickness was associated with a sensitivity reduction of 3.47 dB in scotopic and 0.79 dB in mesopic testing. This study demonstrates progressive outer retinal degeneration and impairment of photoreceptor function in eyes with iAMD and RPD over three years. Preservation of outer retinal thickness and reduction of RPD formation may constitute meaningful surrogate endpoints in interventional trials on eyes with AMD and RPD aiming to slow outer retinal degeneration.

Identifiants

pubmed: 32780863
pii: 2770626
doi: 10.1167/iovs.61.10.19
pmc: PMC7441376
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19

Références

Ophthalmol Retina. 2020 Mar;4(3):274-283
pubmed: 31924545
Transl Vis Sci Technol. 2017 Jul 13;6(4):7
pubmed: 28713647
Ophthalmology. 2015 Oct;122(10):2053-62
pubmed: 26253372
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD19-AMD24
pubmed: 29860308
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4267-74
pubmed: 26161988
Ophthalmology. 2020 May;127(5):648-659
pubmed: 32081493
Retina. 2020 Jun;40(6):1124-1131
pubmed: 30829989
Retina. 2020 Feb 06;:
pubmed: 32032256
Ophthalmology. 2019 Jun;126(6):829-838
pubmed: 30244144
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2015-8
pubmed: 10892836
Ophthalmology. 2008 Nov;115(11):1883-90
pubmed: 18722666
Retina. 2013 Feb;33(2):265-76
pubmed: 23266879
Invest Ophthalmol Vis Sci. 2012 Mar 09;53(3):1258-63
pubmed: 22222508
Am J Ophthalmol. 2016 Aug;168:52-61
pubmed: 27163235
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD152-AMD159
pubmed: 30372731
Retina. 2020 Apr;40(4):618-631
pubmed: 31599795
Ophthalmology. 2010 Jun;117(6):1169-76
pubmed: 20163861
Am J Ophthalmol. 2018 May;189:127-138
pubmed: 29477964
Ophthalmology. 2013 Apr;120(4):844-51
pubmed: 23332590
Eye (Lond). 2018 Dec;32(12):1819-1830
pubmed: 30068928
Ophthalmology. 2009 Mar;116(3):488-496.e2
pubmed: 19167082
JAMA Ophthalmol. 2015 Jun;133(6):690-7
pubmed: 25811917
Ophthalmology. 2016 Jun;123(6):1320-31
pubmed: 27039021
Eye (Lond). 2017 Sep;31(9):1345-1357
pubmed: 28820184
Surv Ophthalmol. 2019 May - Jun;64(3):353-364
pubmed: 30703401
Invest Ophthalmol Vis Sci. 2014 Aug 21;55(9):6073-81
pubmed: 25146989
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
Am J Ophthalmol. 2013 Dec;156(6):1184-1191.e2
pubmed: 23972310
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4154-4161
pubmed: 30105370
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2411-2421
pubmed: 29847647
Ophthalmology. 2010 Feb;117(2):303-12.e1
pubmed: 19815280
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
pubmed: 8641827
Sci Rep. 2019 Oct 25;9(1):15326
pubmed: 31653904
Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6263-70
pubmed: 22918638
Ophthalmologe. 2014 Aug;111(8):765-71
pubmed: 24114561
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):2100-6
pubmed: 25736790
Retina. 2013 Oct;33(9):1800-8
pubmed: 23764969
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3714-22
pubmed: 27415789
Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):5009-15
pubmed: 21498612
Am J Ophthalmol. 2017 Feb;174:42-55
pubmed: 27794427
Br J Ophthalmol. 2007 Nov;91(11):1499-503
pubmed: 17504849
Clin Exp Optom. 2019 Nov;102(6):601-610
pubmed: 30883919
Invest Ophthalmol Vis Sci. 2014 May 02;55(5):2911-20
pubmed: 24699379
Eye (Lond). 2017 Jul;31(7):985-994
pubmed: 28257134
Br J Ophthalmol. 2015 Sep;99(9):1289-94
pubmed: 25795913
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1511-1518
pubmed: 30994862
Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1603-12
pubmed: 23361506

Auteurs

Marlene Sassmannshausen (M)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
GRADE Reading Center, Bonn, Germany.

Maximilian Pfau (M)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
GRADE Reading Center, Bonn, Germany.
Department of Biomedical Data Science, Stanford University, Stanford, California, United States.

Sarah Thiele (S)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
GRADE Reading Center, Bonn, Germany.

Rolf Fimmers (R)

Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Medical Faculty, Bonn, Germany.

Julia S Steinberg (JS)

Department of Ophthalmology, University of Bonn, Bonn, Germany.

Monika Fleckenstein (M)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, United States.

Frank G Holz (FG)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
GRADE Reading Center, Bonn, Germany.

Steffen Schmitz-Valckenberg (S)

Department of Ophthalmology, University of Bonn, Bonn, Germany.
GRADE Reading Center, Bonn, Germany.
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH